cgocorp.com 1
CSE : CGOC
NOVEMBER 2019
CORPORATE PRESENTATION NOVEMBER 2019 Long-term Success in Cannabis - - PowerPoint PPT Presentation
CSE : CGOC CORPORATE PRESENTATION NOVEMBER 2019 Long-term Success in Cannabis Investing cgocorp.com 1 Disclaimer The presented materials and accompanying oral presentation may constitute forward -looking information within the meaning
cgocorp.com 1
NOVEMBER 2019
cgocorp.com 2
The presented materials and accompanying oral presentation may constitute “forward-looking information” within the meaning of Canadian securities laws and are based on expectations, estimates and projections as of the date of this presentation. Forward-looking statements include, without limitation, statements with respect to: a) the completion of the Offering and receipt of all regulatory approvals in connection therewith; b) the use of the net proceeds of the Offering; c) the availability of investment opportunities; d) the performance of the Corporation’s business and operations; e) applicable laws, regulations and any amendments thereof including, but not limited to, the legalization of cannabis and the timing thereto; f) the competitive and business strategies of the Corporation; g) statements related to the effect and consequences of certain regulatory initiatives; h) the expected growth of the cannabis sector; i) the competitive conditions of the industry; j) the Corporation’s investments in the U.S. and consequences of those investments under U.S. federal law; and k) the anticipated changes to laws regarding the recreational use of cannabis and the business impacts on the Corporation Forward-looking statements are necessarily based upon management’s perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by management as of the date on which the statements are made in this presentation, are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being incorrect. In addition to the various factors and assumptions set forth in this presentation, the material factors and assumptions used to develop the forward-looking information include, but are not limited to: general economic, financial market, regulatory and political conditions in which the Corporation operates will continue to improve; the Corporation will be able to compete in the industry; the Corporation will be able to make investments on suitable terms; issuers in the Portfolio will be able to meet their objectives and financial estimates and that the risk factors noted below, collectively, do not have a material impact on the Corporation.
By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. Known and unknown risk factors, many of which are beyond the control of the Corporation could cause actual results to differ materially from the forward-looking information in this presentation. Such factors, without limitation, include the following, which are discussed in greater detail in the “Risk Factors” section of the Prospectus: there is no assurance that the Corporation will be able to achieve its investment objectives; risks relating to the Portfolio issuers; risks relating to medical cannabis; risks relating to risk and timing of legalization of recreational cannabis; regulatory risks; risks relating to the performance of the Portfolio issuers; risks relating to the licensing process; no current market for Common Shares or Warrants; risks relating to recent and future global financial developments; industry concentration risks; risks associated with investment in illiquid and private securities; risk factors related to U.S. cannabis legislation; changes to the cannabis laws; United States anti-money laundering laws and regulations; investments in U.S. cannabis sector; short selling; use of the Prime Broker to hold assets; sensitivity to interest rates; reliance on the Manager and Investment Manager; conflicts of interest; risks related to dilution; loss of investment; risks relating to currency exposure; risks relating to foreign market exposure; lack of operating history; risks related to the exchange option; and tax risks. These risk factors are not intended to represent a complete list of the factors that could affect the Corporation and investors are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management’s expectations and plans relating to the future. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or
Terms undefined herein have the meanings ascribed to them in the Prospectus. An investor should rely only on the information contained in the Prospectus. This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the detailed information appearing in the Prospectus. Neither the Corporation nor the Agent has authorized anyone to provide investors with different or additional information. The Corporation is not offering, or soliciting offers to acquire, the securities in any jurisdiction in which the offer is not permitted. For purchasers outside Canada, neither the Corporation nor the Agent have done anything that would permit the offering or distribution of this presentation together with the Prospectus in any jurisdiction where action for that purpose is required, other than in Canada. An investor is required to inform itself about and to observe any restrictions relating to the planned public offering and the distribution of this presentation and of the Prospectus. No securities regulatory authority has expressed an opinion about the securities of the Corporation discussed in this presentation and it is an offence to claim otherwise. The securities of the Corporation discussed in this presentation have not been, and will not be, registered under the U.S. Securities Act, or the securities laws of any state of the United States and, subject to certain exceptions, may not be offered, sold or delivered, directly or indirectly, in the United States except pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This presentation does not constitute an offer to sell or solicitation of an offer to buy any of the securities of the Trust in the United States. An investment in the securities offered by the Prospectus must be considered speculative as the securities are subject to certain risk factors as set out under the heading “Risk Factors” in the Prospectus or otherwise described in the Prospectus. An investment in Units of the Corporation is appropriate only for investors who have the capacity to absorb a loss of some or all of their investment. Investors should also review the financial statements included in the Prospectus.
cgocorp.com 2
cgocorp.com 3
have ma made de th the ri right ht de deci cisi sion
s to s
tay ahe head d of
the c cur urve
have ta taken a n a p prud udent nt a app pproa
ch to to ou
priv ivat ate po portfol
io, wh where we n now s w see si sign gnif ific icant nt ga gain ins pa s payin ing of g off
have cr creat ated a v d a vehi hicl cle su suite ited f d for
not on
he a average age retail il in investor stor, bu but for for any nyon
look
ing g for
ue di diversi sific ficati ation
in c cann nnabi bis s in in or
der to ac to achi hieve lo long ng-term m su succ ccess ss
cgocorp.com 4
Div iversif rsific ication: ion: A diversified and actively managed portfolio
investing in both public and private cannabis companies globally
Gate Gateway y to to the he US: S: Ability to take advantage of significant
valuation discrepancies with early access into US private companies
Gl Glob
l Reach: ch: Ability to invest globally and be a first mover in the
global emerging markets
Sm Smart Capi pital al: : Pre-IPO deal flow through our network effect –
supporting sustainable deal flow from the extended network
cgocorp.com 5
Supplie liers rs Pr Prod
uction tion Con
sumer er Pr Prod
ucts ts Retail il & & Dis istrib ibutio ution Se Services ices
Cannab nabinoid inoid Therap rapeutics utics
Fin inance nce Real l Est Estate Hemp Pr Prod
ucts ts
CGOC has also invested in
Traditional Industry
cgocorp.com 6
Private US Investments across 18 states
cgocorp.com 7
In Investors stors Priv ivat ate Co’s Pub ubli lic c Co’s
Gain exposur sure to to mor
so sophi histi sticated d inst stit ituti ution
sh shareh ehol
ders Gain name exposur
to to public mark rkets ts Partne tnershi rships ps and M& M&A o A oppor portuniti ities
Ga Gain ac acces ess to
essional
man anaged ged diver ersifi ified ed por
tfol
io Ga Gain ac acces ess to private e inves estme tment nts s
Gain st strateg egic advi visor sory y from
GOC
cgocorp.com 8
CGOC:CSE
cgocorp.com 9
*Portfolio breakdown at cost
Ge Geog
raphic hical al Br Break eakdo down wn of
Public c an and Priv ivate e Por
tfol
ios Br Break eakdown wn of
Investment estment Sp Split t ac acros
the Public and Private Portfolio’s
41% 59% 0% 27% 27% 41% 41% 32% 32%
Percentage of Private Portfolio
US Canadian International 60% 60% 38% 38% 2% 2%
Percentage of Public Portfolio
US Canadian International
cgocorp.com 10
Funded Capacity and Rec
Cultivation and Medical
Extracted Products, CPG, R.O.W.
Rec and Supply Agreements, USA
cgocorp.com 11
Canada
United States
International
cgocorp.com 12
A diversified portfolio of public companies focused on maximizing long-term
with a focus of staying ahead of the curve.
CSE: BHNG (USA SA) Award winning house of cannabis & hemp brands Not yet list sted ed (USA) Vertically integrated producer in California CSE: CXXI (USA SA) Vertically integrated producer of cannabis and hemp derived consumer products CSE: NGW (USA SA) Vertically integrated producer, known as one of California’s best consumer packaged goods brands Not yet list sted ed (USA) Grassroots is focused on vertical integration in limited licensed medical markets CSE: PL PLTH H (USA SA) Vertically integrated cannabis company based in Nevada, (Planet 13 Cannabis Entertainment Complex) CSE: CANN (Cana anada da) Vertically integrated cannabis provider CSE: TER ER (Cana anada da) Provides quality products, brands and services to global cannabinoid market NEX EX: JU JUSH.B (USA SA) Building a vertically integrated MSO of cannabis and hemp licenses TSX-V: : VIVO (Cana anada da) Pharma and recreational
cgocorp.com 13
Our private portfolio companies have seen enormous success and have and continue to positively impact our NAV.
. Canada da Merchant bank, actively investing in new and innovative US enterprises Canada da & US US Cannabis wellness and lifestyle brand North th Maced acedonia
Producer of premium medical cannabis products for European markets US (Cali alifornia
Creating biologically active and nutrient dense biochar soils for commercial agriculture Canada da (Quebec) ec) World-class cannabis centre site, supporting cannabis innovators Canada da Supporting many top tier brands in cannabis US US Facilitates partnerships between farmers and consumers Canada da Consumer healthcare with products under the brand SannaTM
TM
Canada da LP furthering the science of medical cannabis Canada da A vertically integrated producer & distributor Jamai maica Lowest cost producers globally, located in an ideal natural climate Israel ael Agri-Co licensed to produce and supply medical cannabis Canada da (Aura Cannabis) An independent Canadian cannabis retailer US (Cali alifornia
vertically integrated direct-to consumer Canada/ da/ Israel ael Development and commercialization of pharmaceutical cannabis Canada da Next generation R&D biopharmaceutical company US (Cali alifornia
Application software connecting users with lifestyle brands Switz tzer erlan and Biodynamic agriculture creating sustainable
products Canada da Merchant bank, actively investing in new and innovative US enterprises
cgocorp.com 14
RECENT GO PUBLIC TRANSACTION IM Cannabis Corp (formerly I.M.C. Holdings Ltd.) completed its RTO transaction and listed on the CSE under the symbol “IMCC”, on November 5, 2019, and closed its first day of trading at $0.63. CGOC invested $250,000 CAD in IMCC in May of 2018, receiving 62,500 common shares and 31,250 warrants.
IM Cannabis is a leading medical cannabis provider. Since 2010, the company has offered a full spectrum of government- licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. IMCC is an industrial innovator, constantly moving forward in the rapidly developing medical cannabis market and closely collaborating with research institutions and start-up companies. IMCC is based in Israel & expanding internationally, currently focusing on the EU market. IMC initiated its strategy by acquiring a pharmaceutical distribution company in Germany with all licenses required for distribution of medical cannabis throughout Europe. IMC’s supply of EU-GMP pharma-grade medical cannabis products is available from a variety of sources, both EU cultivation farms, as well as Israeli farms. IMC has formed strong strategic alliances within the international medical cannabis industry and has developed a long-term, IP-protected product portfolio.
cgocorp.com 15
Private Portfolio – Case Study of Meaningful Acquisitions
Feb/ 2018 - investment of $450,000 for 175,000 shares at $2.75 per share. May 30/2018 Harvest One acquired DreamWater for a combination of cash and shares with a total value of $34.5 million.
ROI I of
55% in in 3 3 m mon
hs
Apr/2018 – investment of $2,009,000 for 205 common shares at $9,800 per share. On March 4, 2019, Aurora Cannabis completed the acquisition of Whistler Medical payable in three tranches, subject to certain milestones.
Total l ROI I wi will ll be be c calc lcul ulat ated d
ce fin inal l tr tranc nche he is pa is paid id
cgocorp.com 16
Private Portfolio – Case Study of Meaningful Liquidity Events
Aug/ 2018 – Initial investment of $750,000 for 1,250,000 unites at $0.60 per unit. Completed its RTO transaction to commence trading on the CSE under the symbol “NGW”, on Oct/10/2018 Divested of 11%, remainder is still held in public portfolio.
ROI I of
38% % in 3 mon months ths ROI I of
188% 8% in 9 mon
ths
Jul/ 2018 – Initial investment of $1,971,710 for 33,500 units at $57.23 per unit. Vireo completed its RTO transaction and commenced trading on the CSE under the symbol “VREO”, on March 20, 2019 at an opening price of $5.65 (units converted at exchange ratio of 30.0048 into 1,005,161 common shares) . Still held in the public portfolio Mar/ 2018 – Initial investment of $1,962,090 for 1,500,000 common shares & 1,500,000 Warrants. Jushi completed its RTO transaction and commenced trading on the NEO Exchange under the symbol “ JUSH.B”,
$3.20 (only common shares taken into account in ROI calculation). Still held in the public portfolio
ROI I of
178% 8% in 15 mon
ths
cgocorp.com 17
CGOC:CSE
cgocorp.com 18
V as s of Nov/15 v/15 = $2 $2.5 .51 1 perform
ng well against st our benchma hmarks rks
V decrea ease se of 9% 9% YTD TD
V increase se of 8% 8% si since inception
*HMJR from February 14, 2018, **Jan 26 starting NAV after agent’s fee $2.3171
CGOC strategy has resulted in portfolio gains and reduced downside through industry volatility
0.1 0.2 0.3 Sep 17 VS Aug 13 Oct 15 VS Sep 17 Nov 15 VS Oct 15 Dec 17 VS Nov 15 Jan 15 VS Dec 17 Feb 15 VS Jan 15 Mar 15 VS Feb 15 Apr 15 VS Mar 15 May 15 VS Apr 15 June 14 VS May 15 July 15 VS June 14 August 15 VS July 15 Sept 16 VS Aug 15 Oct15 VS Sept 16 HMMJ HMJR NAMMAR CGOC NAV November 15 VS Inception
8%
61%
71%
67% 8% 8%
cgocorp.com 19
cgocorp.com 20
CGOC:CSE
positively impact the NAV going forward and demonstrate the opportunity available for investors
liquidity than investing directly into the privates
markets (such as Europe)
cgocorp.com 21
CGOC:CSE
cgocorp.com 22
Experienced leadership and operational team
Sean Conache nacher Director, CEO Ex Experi rience enced d and d demons nstra trated ed leade der workin ing in the fi finan ancia cial l servi vices ces and d marketin ting sectors
skill illed ed in n entrepr epreneu eneursh rship, p, ventur ure capi pital al, public ublic and d priv ivate e equi uity, , foreign ign exchange hange, , optio ptions ns and nd as asset set manag agem ement.
EO and d found nder er of G f GCI Corpo rpora ration, tion, a vertic icall ally y integrat egrated ed cannab nnabis s company any. . Bruce ce Campb pbell ell Portfolio Manager 24+ + years rs of i f inves estment ent manage agement ent experie erience nce and d an activ ive e cannabis nnabis inves estor
ince 2013 013. Founde under r and d Portfol
nager ger of f Sto tone e Cas astle tle Inves estment ent Mana nage gement ent Paul Andersen, CPA, CA Director & CFO
Over 20 years of experience as a senior officer and/or director of numerous public and private. Cannabis-specific experience and currently serves as director of Canada House Wellness Group Inc., and has worked as a consultant with a privately owned Oregon-based cannabis company.
Nick J. Richards Independent Director
Practicing tax attorney, adjunct professor of law and legal specialist to the United States cannabis industry, advising businesses and owners throughout the U.S., and is licensed to practice law in California and Colorado.
Brayden Sutton Independent Director
Co-founded and served as EVP for Supreme Pharmaceuticals from 2013 – 2014 and played an instrumental role in the early days of Invictus MD Strategies Corp., Aurora Cannabis Inc. and CannaRoyalty Corp. Throughout his career, Mr. Sutton has played a major role in restructurings, reverse takeovers, IPOs and M&As
John Durfy Independent Director
25+ years of senior investment and financial management experience. Previously CIO at a hedge fund and prior to that, Managing Director of Global Equities for the Ontario Municipal Employees Retirement System (“OMERS”) from 2008-2011.
Gary Yeoman Independent Director
From 2005 to 2011, Mr. Yeoman served as the CEO of Altus Group, and led the company through a seven-year growth period. Previously Chairman of the board of Golden Leaf Holdings and Executive Chair of iLOOKABOUT.
Ja Jamie Blund undell ell Director, President & COO 25+ + years rs of e f experie erience ce in senior nior lead adersh ership ip roles es, , exte tensi nsive e experie erience ce with th M&A, , priv ivate e equit uity y fi firms and d large ge corpo pora rate e dives estit titur ures es.
cgocorp.com 23
Access to the knowledge and expertise needed to build and grow a diversified portfolio of public and private investments globally, to minimize downside risk, while participating in the long-term upside.
A portfolio of
Public Cannabis Businesses
A portfolio of
Private Cannabis Businesses
cgocorp.com 24
Investing across the whole ecosystem multiplies the potential
extraction(1)
(1) Source: Latest Research reports from Cowen and Company (2) Source: Deloitte
Suppliers
Seeds, fertilizers, etc.
Production
Cultivation
Research and development
Extraction
Analytical equipment & services Production equipment, security & infrastructure Software
Retail and Distribution
Online / ecommerce Stores, consumption locations
Consumer Products
Flower and
Edibles, tinctures, topicals, infused etc. Delivery Systems (vaporizers, pipes, rolling papers, etc.) Apparel Packaging & distribution
Services
Buildings, equipment Business, regulatory, legal, etc. Marketing Pharmaceuticals Nutraceuticals Fiber, seeds, food
Cannabinoid Therapeutics Finance Real Estate Hemp
Capital, structuring CGOC has also invested in
Traditional Industry
cgocorp.com 25
➢ A total of 33 states have legalized medicinal marijuana, and 10 states have legalized recreational use ➢ The US continues to be a driving force in production and consumption with California being the second largest market globally ➢ US MARKET SHARE alone expected to account for US$63 Billion at maturity
Upcoming Catalysts:
➢ The STATES Act, is expected to pass in 2019 – which will grant regulatory power to the individual states ➢ SAFE (Secure And Fair Enforcement) Banking act has 20 cosponsors in the Senate, and would protect banks and other institutions from federal prosecution when working with cannabis-related business.
US States Continue to Move Towards Legalization Canadian Developments
➢ Ahead of the legalization of extracted goods (such as edibles, vapes and infused beverages), many Canadian companies are in the midst of intense R&D and product roll out, as well as partnering with known brands in the US for supply control and brand recognition ➢ Canadian market expected to remain undersupplied until 2020
* source: Eight Capital
cgocorp.com 26
* source: Eight Capital
International Developments
➢ Medical Cannabis now officially regulated in over 50 countries world-wide, with more than 2 dozen of these centered within Europe ➢ Columbia and Israel have approved the exportation of cannabis ➢ Europe is opening up with many countries rapidly adapting their laws and adopting medical use cannabis GL GLOBA BAL CA L CANN NNABIS ABIS MARKE KET T an anti ticip ipated ed to
e wor
th US$ S$170 170 Bi Billio ion n ac acros
a a 10-15 15 yea ear r ti time e hor
zon The e glob
al lan andsc scape ape is ch chan anging ing rap apid idly, , crea eating ting com
titi tion
trol
supply y
both th THC HC an and CB CBD; p ; prop
rietary tary ex extracti traction
thod
, rec ecipes pes an and for
mulas bei eing g rea eadil ily y sou
ht af after er; ; an and on
e of
the e biggest est bran and d crea eati tion
and rec ecogn
itio ion n battl tles es
all ti time me.
cgocorp.com 27
Tech chni nicals ls Lead P d Pric ice
April 2018 January 2019 January 2019
Ap April il 2019 2019
cgocorp.com 28
A Changing Environment Requires Continuous Monitoring of Information Keeping up to date on a fast-changing environment on the regulatory as well as investor sentiment side – We stay in the know!
Rapid regulatory change (local & global) Implication Key investing behaviors required to succeed: Active management, access to privates, timing investments US market attractiveness increasing Reasons Experienced operators + meaningful REV & EBITDA US capital is starting to increase rapidly Implication Need to focus & actively invest in US privates Privates need help navigating capital markets Implication Continue to focus and build capabilities to help privates access, navigate and succeed with the capital markets and M&A opportunities CGOC network effect working Implication Continue to connect investors, publics and privates and drive the CGOC network effect: trust